
The net profit of one of the largest vaccine manufacturers in CHINA, Sinovac, grew 78 times in 2021 and reached about $14.5 billion, BLOOMBERG reports, citing the company's financial report.
“Net profit at the end of 2021 amounted to $14.5 billion compared to $185.2 million a year earlier. Net profit increased mainly due to sales growth <...> sales in 2021 amounted to $19.4 billion, up from $510.6 million a year earlier
To date, Sinovac has delivered more than 2.8 billion doses of CoronaVac vaccine to various countries around the world, of which 300 million doses have been transferred to various institutions of the Chinese healthcare system, the document notes.
Beijing authorities close schools and kindergartens due to outbreak of covid-19 Society
In China, a new outbreak of COVID-19 infections has been observed since the beginning of the year. Most of the new cases were recorded in Shanghai - more than 21 thousand on April 21. The city has been in quarantine for a month now: most businesses, markets and shops have stopped working, people have been ordered to stay at home.
As in many countries around the world, the majority of detected cases of COVID-19 in China are in the stealth omicron strain. At the end of April, the new strain had already been detected in more than a hundred countries. In RUSSIA, "stealth-omicron" became the most common strain of CORONAVIRUS in early April - it accounted for 80% of cases.
Spread of coronavirus Covid-19 in the world April 30 Number of confirmed cases of infection <1000 0 <100,000 0 <1,000,000 0 <10,000,000 0 from 10,000,000 0 Created with Highmaps 5.0.10025M50M75M100MZoom in+Zoom out- Source: JHU Data around the world i